TY - JOUR
T1 - Absence of fluoride varnish-related adverse events in caries prevention trials in young children, United States
AU - Garcia, Raul I.
AU - Gregorich, Steven E.
AU - Ramos-Gomez, Francisco
AU - Braun, Patricia A.
AU - Wilson, Anne
AU - Albino, Judith
AU - Tiwari, Tamanna
AU - Harper, Maya
AU - Batliner, Terrence S.
AU - Rasmussen, Margaret
AU - Cheng, Nancy F.
AU - Santo, William
AU - Geltman, Paul L.
AU - Henshaw, Michelle
AU - Gansky, Stuart A.
PY - 2017
Y1 - 2017
N2 - Introduction Fluoride varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analysesand recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to fluoride varnish treatment in young children. Methods We determined the incidence of adverse events related to fluoride varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of fluoride varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each fluoride varnish treatment. Results A total of 2,424community-dwelling,dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 fluoride varnish treatments. On average, each child received 4.2 fluoride varnish treatments. We found zero fluoride varnish-related adverse events. Conclusion Fluoride varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.
AB - Introduction Fluoride varnish is an effective prevention intervention for caries in young children. Its routine use in clinical care is supported by meta-analysesand recommended by clinical guidelines, including the US Preventive Services Task Force (B rating). This report is the first prospective systematic assessment of adverse events related to fluoride varnish treatment in young children. Methods We determined the incidence of adverse events related to fluoride varnish treatment in 3 clinical trials on the prevention of early childhood caries, conducted under the auspices of the Early Childhood Caries Collaborating Centers, an initiative sponsored by the National Institute of Dental and Craniofacial Research. Each trial incorporated use of fluoride varnish in its protocol and systematically queried all children's parents or legal guardians about the occurrence of acute adverse events after each fluoride varnish treatment. Results A total of 2,424community-dwelling,dentate children aged 0 to 5 years were enrolled and followed for up to 3 years. These children received a cumulative total of 10,249 fluoride varnish treatments. On average, each child received 4.2 fluoride varnish treatments. We found zero fluoride varnish-related adverse events. Conclusion Fluoride varnish was not associated with treatment-related adverse events in young children. Our findings support its safety as an effective prevention intervention for caries in young children.
UR - https://www.scopus.com/pages/publications/85013243958
UR - https://www.scopus.com/pages/publications/85013243958#tab=citedBy
U2 - 10.5888/pcd14.160372
DO - 10.5888/pcd14.160372
M3 - Article
C2 - 28207379
AN - SCOPUS:85013243958
SN - 1545-1151
VL - 14
JO - Preventing Chronic Disease
JF - Preventing Chronic Disease
IS - 2
M1 - 160372
ER -